3 hours Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?The Motley Fool
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
Earnings · Johnson & Johnson (JNJ) · NYSE · Pharmaceuticals · Tech · Wall Street
X